Clinical Research News
-
CStone Pharmaceuticals announces dosing in Ph III trial for treating adenocarcinoma
Clinical Research | News | 0 Comment | 16 Apr, 2019
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...Read more
-
CStone receives IND approval in China for avapritinib study
Clinical Research | News | 0 Comment | 15 Apr, 2019
CStone Pharmaceuticals has announced that the National Medical Products Administration (NMPA) recently approved the init...Read more
-
I-Mab Biopharma collaborates with Roche for combination therapy
Clinical Research | News | 0 Comment | 11 Apr, 2019
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential ...Read more
-
George Clinical establishes new presence in Singapore
Clinical Research | News | 0 Comment | 10 Apr, 2019
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in ...Read more
-
NIH begins first-in-human trial of a universal influenza vaccine candidate
Clinical Research | News | 0 Comment | 05 Apr, 2019
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...Read more
-
Veeda Clinical Research Achieves ISO 27001:2013 Certification
Clinical Research | News | 0 Comment | 03 Apr, 2019
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has award...Read more
-
Veeda Clinical Research successfully completes third inspection by NPRA
Clinical Research | News | 0 Comment | 27 Mar, 2019
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and B...Read more
-
Eisai starts Phase III clinical trial for Alzheimer's drug
Clinical Research | News | 0 Comment | 25 Mar, 2019
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...Read more
-
WCG introduces a transformational solution for clinical research sites
Clinical Research | News | 0 Comment | 20 Mar, 2019
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and ...Read more
-
Clinical Research | News | 0 Comment | 18 Mar, 2019
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the Nationa...Read more
-
Clinical Research | News | 0 Comment | 15 Mar, 2019
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinic...Read more
-
Alvotech enrolls first patient for Ph III study involving Biosimilar version of HUMIRA
Clinical Research | News | 0 Comment | 14 Mar, 2019
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical...Read more
-
Kezar Life Sciences to test a new drug formulation of KZR-616
Clinical Research | News | 0 Comment | 07 Mar, 2019
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing n...Read more
-
Dr Albers receives the distinguished Clinical Research Achievement Award for stroke research
Clinical Research | News | 0 Comment | 07 Mar, 2019
iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaVie...Read more
-
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial
Clinical Research | News | 0 Comment | 25 Feb, 2019
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...Read more
-
Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer
Clinical Research | News | 0 Comment | 22 Feb, 2019
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced tha...Read more
-
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Clinical Research | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing...Read more
-
Owlstone Medical partners with Shanghai Renji Hospital
Clinical Research | News | 0 Comment | 25 Feb, 2019
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precis...Read more
